Marketing-authorisation holder
Vetviva Richter GmbH
4 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AURIMIC23 mg / ml + 0.5293 mg / ml + 5 mg / ml · Suspension | Miconazole, Polymyxin b, Prednisolone | Canada | Marketed | 2022 |
| BUPAQ0.3 mg / ml · Solution | Buprenorphine | Canada | Marketed | 2022 |
| BUTOMIDOR10 mg / ml · Solution | Butorphanol | Canada | Authorised | |
| RIFEN100 mg / ml · Solution | Ketoprofen | Canada | Marketed | 2022 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 4 | 4 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- vetviva richter
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 4
- Countries
- 1
- Roles
- Authorisation holder